Anti-CD26 antibodies and methods of use thereof

Details for Australian Patent Application No. 2006272713 (hide)

Owner Y'S Therapeutics, Inc.

Inventors Luo, Peizhi; Morimoto, Chikao; Wang, Caili C.; Zhong, Pingyu; Aoyagi, Teikichi; Hsieh, Mark; Li, Yan

Agent FB Rice

Pub. Number AU-A-2006272713

PCT Pub. Number WO2007/014169

Priority 60/701,802 22.07.05 US

Filing date 24 July 2006

Wipo publication date 1 February 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/014169 Priority application(s): WO2007/014169

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272714-Compositions and methods for protein deaggregation

2006272706-Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis